Treatment Response and Tolerability of Pegylated Interferon-α PlusRibavirin Combination Therapy in Elderly Patients (≥ 65 years) WithChronic Hepatitis C in Korea

Sang Wook Kim; In Hee Kim; Seung-Ok Lee

Treatment Response and Tolerability of Pegylated Interferon-α PlusRibavirin Combination Therapy in Elderly Patients (≥ 65 years) WithChronic Hepatitis C in Korea

Department of Medicine

Research output: Contribution to journal › Journal article › peer-review

Original language	Korean
Journal	Hepatitis Monthly
State	Published - 2012.05.17

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

@article{dd877e9b36dc4541a102efc09d756683,

title = "Treatment Response and Tolerability of Pegylated Interferon-α PlusRibavirin Combination Therapy in Elderly Patients (≥ 65 years) WithChronic Hepatitis C in Korea",

author = "Kim, \{Sang Wook\} and Kim, \{In Hee\} and Seung-Ok Lee",

year = "2012",

month = may,

day = "17",

language = "Korean",

journal = "Hepatitis Monthly",

issn = "1735-143X",

}